glp-1 direct to consumer The New Era of Direct-to-Consumer Pharmaceutical Care Maven Clinic Launches Direct-to-Consumer Platform

BMC biotechnology, 21, pp.1-10

Anaesthesia 2024;79:1317-24.ArticlePubMed 19

How it works: Increases growth hormone production Specifically targets visceral (belly) fat Improves insulin sensitivity Expected results: Significant visceral fat reduction May not affect subcutaneous fat as much Better metabolic markers Dosing: 1-2mg daily, subcutaneous Best for: People with significant belly fat, metabolic syndrome, insulin resistance, post-menopausal women with visceral fat accumulation

At only $110, the normal saline IV package is an incredible deal, and the other packages on our menu top out at $625

Tirzepatide works by targeting the GIP and GLP-1 pathways, which improve insulin response